HC Wainwright & Co. Initiates Coverage On AngioDynamics With Buy Rating, Announces Price Target of $19
HC Wainwright & Co. Initiates Coverage On AngioDynamics With Buy Rating, Announces Price Target of $19
HC Wainwright & Co.以买入评级开始对AngiOdynamics进行报道，宣布目标股价为19美元
HC Wainwright & Co. analyst Yi Chen initiates coverage on AngioDynamics (NASDAQ:ANGO) with a Buy rating and announces Price Target of $19.
HC Wainwright&Co.分析师陈毅在AngioDynamic(纳斯达克代码：ANGO)上以买入评级开始报道，并宣布目标价为19美元。
译文内容由第三方软件翻译。
以上内容仅用作资讯或教育之目的，不构成与富途相关的任何投资建议。富途竭力但不能保证上述全部内容的真实性、准确性和原创性。